Glycine consumption and mitochondrial serine hydroxymethyltransferase in cancer cells: The heme connection

Medical Hypotheses

Volumn 80, Issue 5, 2013, Pages 633-636

  di Salvo, Martino L ^a   Contestabile, Roberto ^a   Paiardini, Alessandro ^a   Maras, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CORE; SHMT1; SHMT2

Indexed keywords

GLYCINE; GLYCINE HYDROXYMETHYLTRANSFERASE; GLYCINE HYDROXYMETHYLTRANSFERASE 1; GLYCINE HYDROXYMETHYLTRANSFERASE 2; HEME; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL METABOLISM; CELL RESPIRATION; HEME SYNTHESIS; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PROTEIN FUNCTION;

ANIMALS; GLYCINE HYDROXYMETHYLTRANSFERASE; HEME; HUMANS; METABOLIC CLEARANCE RATE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHORYLATION;

EID: 84875616592     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.02.008     Document Type: Article

References (34)

1. DeBerardinis R.J. Serine metabolism: some tumors take the road less traveled. Cell Metab 2011, 14:285-286.
2. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011, 11:325-337.
3. Locasale J.W., Grassian A.R., Melman T., Lyssiotis C.A., Mattaini K.R., Bass A.J., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011, 43:869-874.
4. Possemato R., Marks K.M., Shaul Y.D., Pacold M.E., Kim D., Birsoy K., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476:346-350.
5. Tibbetts A.S., Appling D.R. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu Rev Nutr 2010, 30:57-81.
6. Stover P.J., Field M.S. Trafficking of intracellular folates. Adv Nutr 2011, 2:325-331.
7. Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336:1040-1044.
8. Fu T.F., Rife J.P., Schirch V. The role of serine hydroxymethyltransferase isozymes in one-carbon metabolism in MCF-7 cells as determined by (13)C NMR. Arch Biochem Biophys 2001, 393:42-50.
9. MacFarlane A.J., Anderson D.D., Flodby P., Perry C.A., Allen R.H., Stabler S.P., et al. Nuclear localization of de novo thymidylate biosynthesis pathway is required to prevent uracil accumulation in DNA. J Biol Chem 2011, 286:44015-44022.
10. Anderson D.D., Quintero C.M., Stover P.J. Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria. Proc Natl Acad Sci USA 2011, 108:15163-15168.
11. MacFarlane A.J., Liu X., Perry C.A., Flodby P., Allen R.H., Stabler S.P., et al. Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J Biol Chem 2008, 283:25846-25853.
12. Kao F., Chasin L., Puck T.T. Genetics of somatic mammalian cells. X. Complementation analysis of glycine-requiring mutants. Proc Natl Acad Sci USA 1969, 64:1284-1291.
13. Ye Y.L., Chan Y.T., Liu H.C., Lu H.T., Huang R.F. Depleted folate pool and dysfunctional mitochondria associated with defective mitochondrial folate proteins sensitize Chinese ovary cell mutants to tert-butylhydroperoxide-induced oxidative stress and apoptosis. J Nutr Biochem 2010, 21:793-800.
14. Atamna H., Liu J., Ames B.N. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging. J Biol Chem 2001, 276:48410-48416.
15. Kalhan S.C., Hanson R.W. Resurgence of serine: an often neglected but indispensable amino Acid. J Biol Chem 2012, 287:19786-19791.
16. Di Pietro E., Sirois J., Tremblay M.L., MacKenzie R.E. Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol Cell Biol 2002, 22:4158-4166.
17. Schirch V., Szebenyi D.M. Serine hydroxymethyltransferase revisited. Curr Opin Chem Biol 2005, 9:482-487.
18. Florio R., di Salvo M.L., Vivoli M., Contestabile R. Serine hydroxymethyltransferase: a model enzyme for mechanistic, structural, and evolutionary studies. Biochim Biophys Acta 2011, 1814:1489-1496.
19. Szebenyi D.M., Musayev F.N., di Salvo M.L., Safo M.K., Schirch V. Serine hydroxymethyltransferase: role of glu75 and evidence that serine is cleaved by a retroaldol mechanism. Biochemistry 2004, 43:6865-6876.
20. Malerba F., Bellelli A., Giorgi A., Bossa F., Contestabile R. The mechanism of addition of pyridoxal 5'-phosphate to Escherichia coli apo-serine hydroxymethyltransferase. Biochem J 2007, 404:477-485.
21. Pascarella S., Angelaccio S., Contestabile R., Delle Fratte S., Di Salvo M., Bossa F. The structure of serine hydroxymethyltransferase as modeled by homology and validated by site-directed mutagenesis. Protein Sci 1998, 7:1976-1982.
22. Amadasi A., Bertoldi M., Contestabile R., Bettati S., Cellini B., di Salvo M.L., et al. Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents. Curr Med Chem 2007, 14:1291-1324.
23. Daidone F., Montioli R., Paiardini A., Cellini B., Macchiarulo A., Giardina G., et al. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. PLoS one 2012, 7:e31610.
24. Renwick S.B., Snell K., Baumann U. The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy. Structure 1998, 6:1105-1116.
25. Rao N.A., Talwar R., Savithri H.S. Molecular organization, catalytic mechanism and function of serine hydroxymethyltransferase-a potential target for cancer chemotherapy. Int J Biochem Cell Biol 2000, 32:405-416.
26. Cellini B., Oppici E., Paiardini A., Montioli R. Molecular insights into primary hyperoxaluria type 1 pathogenesis. Front Biosci 2012, 17:621-634.
27. Storici P., Capitani G., De Biase D., Moser M., John R.A., Jansonius J.N., et al. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry 1999, 38:8628-8634.
28. Pegg A.E., Shantz L.M., Coleman C.S. Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl 1995, 22:132-138.
29. Snell K., Riches D. Effects of a triazine antifolate (NSC 127755) on serine hydroxymethyltransferase in myeloma cells in culture. Cancer Lett 1989, 44:217-220.
30. Chang W.N., Tsai J.N., Chen B.H., Huang H.S., Fu T.F. Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases. Drug Metab Dispos 2007, 35:2127-2137.
31. Rollins K.D., Lindley C. Pemetrexed: a multitargeted antifolate. Clin Ther 2005, 27:1343-1382.
32. Daidone F., Florio R., Rinaldo S., Contestabile R., di Salvo M.L., Cutruzzola F., et al. In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed. Eur J Med Chem 2011, 46:1616-1621.
33. Bukin Iu V., Sergeev A.V. Comparative sensitivity of mouse liver serine-hydroxymethyltransferase to carbonyl reagents and decrease in activity of the enzyme during B6 deficiency. Biokhimiia 1968, 33:1092-1101.
34. Webb H.K., Matthews R.G. 4-Chlorothreonine is substrate, mechanistic probe, and mechanism-based inactivator of serine hydroxymethyltransferase. J Biol Chem 1995, 270:17204-17209.